Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use ZOLPIDEM TARTRATE SUBLINGUAL TABLETS safely and effectively. See full prescribing information for ZOLPIDEM TARTRATE SUBLINGUAL TABLETS. ZOLPIDEM TARTRATE sublingual tablets, for oral use CIV Initial U.S. Approval: 1992
Medication labelWhy this: Advisory · dailymed-prescription
Zolpidem tartrate sublingual tablets are indicated for use as needed for the treatment of insomnia when a middle-of-the-night awakening is followed by difficulty returning to sleep. Limitations of Us e: Zolpidem tartrate sublingual tablets are not indicated for the treatment of middle-of-the-night insomnia when the patient has fewer than 4 hours of bedtime remaining before the planned time of waking.
- generic_name
- zolpidem tartrate sublingual
- product_names
- Zolpidem tartrate sublingual
- ndc
- 49884-898, 49884-898-52, 49884-898-11, 49884-899, 49884-899-52, 49884-899-11
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en